Relmada Therapeutics, Inc. (RLMD)

4.02 -0.48 (-10.67%) USD  |  NASDAQ  |  Dec 17, 16:00
4.02 0.00 (0.00%) After-Hours: 18:54
More

Relmada Therapeutics EPS Basic from Continuing Operations (Quarterly)

EPS Basic from Continuing Operations (Quarterly) Chart

View EPS Basic from Continuing Operations (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Continuing Operations (Quarterly) Benchmarks

View EPS Basic from Continuing Operations (Quarterly) Benchmarks
Start Trial
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade